Health & Medicine
Aspirin May Interact with Cells' DNA Modifications to Alter Breast Cancer Outcomes
New findings suggest that women with specific DNA characteristics in certain areas of the genome may live longer if they take aspirin before they are diagnosed with breast cancer. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings point to the need for studies on the potential of aspirin to prevent or treat breast cancer in some individuals.
Latest Research Articles
New 'Liquid Biopsy' Blood Test Improves Breast Cancer Diagnostics
Enhanced Glow
Newly Developed Approach Shows Promise in Silencing HIV Infection
Thyme Essential Oil in Corn Starch Particles Combats Aedes Aegypti Larvae
Ofev Drug Fails in Mesothelioma Clinical Trial
Super-Resolution Microscopy Sheds Light on How Dementia Protein Becomes Dysfunctional
Endometrial Diseases Can Be Imitated in a Lab Dish, New Study Shows
WPI Liquid Biopsy Chip Snares Circulating Tumor Cells in Blood Drops from Cancer Patients
Two Therapeutic Targets Identified for Deadly Lung Cancer
Brain Region Linked to Altered Social Interactions in Autism Model
CBD Oil & The Endocannabinoid System
Finnish Company Uses NASA’s Concept to Create Food from Thin Air